Characterisation and protein expression profiling of annexins in colorectal cancer

British Journal of Cancer

Volumn 98, Issue 2, 2008, Pages 426-433

  Duncan, R ^a   Carpenter, B ^b   Main, L C ^a   Telfer, C ^b   Murray, G I ^a,c  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b Auvation Ltd   (United Kingdom)

^c UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

Annexin; Immunohistochemistry; Prognosis; Proteomics; Tissue microarray

Indexed keywords

BINDING PROTEIN; LIPOCORTIN 1; LIPOCORTIN 2; LIPOCORTIN 4; PROTEIN ANNEXIN A11; UNCLASSIFIED DRUG;

ARTICLE; CANCER STAGING; CANCER SURVIVAL; COLORECTAL CANCER; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MALE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEOMICS; TUMOR DIFFERENTIATION;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ANNEXINS; COLORECTAL NEOPLASMS; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; PROTEIN ARRAY ANALYSIS; PROTEOMICS; SURVIVAL ANALYSIS; TISSUE ARRAY ANALYSIS;

EID: 38549174826     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6604128     Document Type: Article

References (44)

1. Babbin BA, Lee WY, Parkos CA, Winfree LM, Akyildiz A, Peretti M, Nusrat A (2006) Annexin I regulates SKCO-15 cell invasion by signaling through formyl peptide receptors. J Biol Chem 28: 19588-19599
2. Bai XF, Ni XG, Zhao P, Liu SM, Wang HX, Guo B, Zhou LP, Liu F, Zhang JS, Wang K, Xie YQ, Shao YF, Zhao XH (2004) Overexpression of annexin 1 in pancreatic cancer and its clinical significance. World J Gastroenterol 10: 1466-1470
3. Coghlin C, Carpenter B, Dundas SR, Lawrie LC, Telfer C, Murray GI (2006) Characterisation and over-expression of chaperonin T-complex proteins in colorectal cancer. J Pathol 210: 351-357
4. Diaz VM, Hurtado M, Thomson TM, Reventos J, Paciucci R (2004) Specific interaction of tissue-type plasminogen activator (t-PA) with annexin II on the membrane of pancreatic cancer cells activates plasminogen and promotes invasion in vitro. Gut 53: 993-1000
5. Dundas SR, Lawrie LC, Rooney PH, Murray GI (2005) Mortalin is overexpressed by colorectal cancer and correlates with poor survival. J Pathol 205: 74-81
6. Emoto K, Yamada Y, Sawada H, Fujimoto H, Ueno M, Takayama T, Kamada K, Naito A, Hirao S, Nakajima Y (2001) Annexin II overexpression correlates with stromal tenascin-C overexpression: a prognostic marker in colorectal carcinoma. Cancer 92: 1419-1426
7. Esposito I, Penzel R, Chaib-Harrireche M, Barcena U, Bergmann F, Riedl S, Kayed H, Giese N, Kleeff J, Friess H, Schirmacher P (2006) Tenascin C and annexin II expression in the process of pancreatic carcinogenesis. J Pathol 208: 673-685
8. Falini B, Tiacci E, Liso A, Basso K, Sabattini E, Pacini R, Foa R, Pulsoni A, Dalla Favera R, Pileri S (2004) Simple diagnostic assay for hairy cell leukaemia by immunocytochemical detection of annexin A1 (ANXA1). Lancet 363: 1869-1870
9. Falsey RR, Marron MT, Gunaherath GM, Shirahatti N, Mahadevan D, Gunatilaka AA, Whitesell L (2006) Actin microfilament aggregation induced by withaferin A is mediated by annexin II. Nat Chem Biol 2: 33-38
10. Farnaes L, Ditzel HJ (2003) Dissecting the cellular functions of annexin XI using recombinant human annexin XI-specific autoantibodies cloned by phage display. J Biol Chem 278: 33120-33126
11. 2+ signalling to membrane dynamics. Nat Rev Mol Cell Biol 6: 449-461
12. Gerke V, Moss SE (2003) Annexins: from structure to function. Physiol Rev 82: 331-371
13. Gillette JM, Chan DC, Nielsen-Preiss SM (2004) Annexin 2 expression is reduced in human osteosarcoma metastases. J Cell Biochem 92: 820-832
14. Gokmen-Polar Y, Murray NR, Velasco MA, Gatalica Z, Fields AP (2001) Elevated protein kinase C betaII is an early promotive event in colon carcinogenesis. Cancer Res 61: 1375-1381
15. Guzman-Aranguez A, Olmo N, Turnay J, Lecona E, Perez-Ramos P, Lopez SI, Lizarbe MA (2005) Differentiation of human colon adenocarcinoma cells alters the expression and intracellular localization of annexins A1, A2, and A5. J Cell Biochem 94: 178-193
16. Han EK, Tahir SK, Cherian SP, Collins N, Ng SC (2000) Modulation of paclitaxel resistance by annexin IV in human cancer cell lines. Br J Cancer 83: 83-88
17. Hayes MJ, Moss SE (2004) Annexins and disease. Biochem Biophys Res Commun 322: 1166-1170
18. Hu N, Flaig MJ, Su H, Shou JZ, Roth MJ, Li WJ, Wang C, Goldstein AM, Li G, Emmert-Buck MR, Taylor PR (2004) Comprehensive characterization of annexin I alterations in esophageal squamous cell carcinoma. Clin Cancer Res 10: 6013-6022
19. Kumarakulasingham M, Rooney PH, Dundas SR, Telfer C, Melvin WT, Curran S, Murray GI (2005) Cytochrome P450 profile of colorectal cancer: identification of markers of prognosis. Clin Cancer Res 11: 3759-3764
20. Lawrie LC, Dundas SR, Curran S, Murray GI (2004) Liver fatty acid binding protein expression in colorectal neoplasia. Br J Cancer 90: 1955-1960
21. Liemann S, Huber R (1997) Three-dimensional structure of annexins. Cell Mol Life Sci 53: 516-521
22. Lim LH, Pervaiz S (2007) Annexin 1: the new face of an old molecule. FASEB J 21: 968-975
23. Mai J, Waisman DM, Sloane BF (2000) Cell surface complex of cathepsin B/ annexin II tetramer in malignant progression. Biochim Biophys Acta 1477: 215-230
24. Murray GI, Duncan ME, O'Neil P, Melvin WT, Fothergill JE (1996) Matrix metalloproteinase-1 is associated with poor prognosis in colorectal cancer. Nat Med 2: 461-462
25. Oh P, Li Y, Yu J, Durr E, Krasinska KM, Carver LA, Testa JE, Schnitzer JE (2004) Subtractive proteomic mapping of the endothelial surface in lung and solid tumours for tissue-specific therapy. Nature 429: 629-635
26. Patton KT, Chen HM, Joseph L, Yang XJ (2005) Decreased annexin I expression in prostatic adenocarcinoma and in high-grade prostatic intraepithelial neoplasia. Histopathology 47: 597-601
27. Paweletz CP, Ornstein DK, Roth MJ, Bichsel VE, Gillespie JW, Calvert VS, Vocke CD, Hewitt SM, Duray PH, Herring J, Wang QH, Hu N, Linehan WM, Taylor PR, Liotta LA, Emmert-Buck MR, Petricoin EF (2000) Loss of annexin 1 correlates with early onset of tumorigenesis in esophageal and prostate carcinoma. Cancer Res 60: 6293-6297
28. Rand JH (2000) The annexinopathies: a new category of diseases. Biochim Biophys Acta 1498: 169-173
29. Rescher U, Gerke V (2004) Annexins - unique membrane binding proteins with diverse functions. J Cell Sci 117: 2631-2639
30. Roda O, Chiva C, Espuna G, Gabius HJ, Real FX, Navarro P, Andreu D (2006) A proteomic approach to the identification of new tPA receptors in pancreatic cancer cells. Proteomics 6(Suppl 1): S36-S41
31. Sharma MR, Koltowski L, Ownbey RT, Tuszynski GP, Sharma MC (2006) Angiogenesis-associated protein annexin II in breast cancer: selective expression in invasive breast cancer and contribution to tumor invasion and progression. Exp Mol Pathol 81: 146-156
32. Shen D, Nooraie F, Elshimali Y, Lonsberry V, He J, Bose S, Chia D, Seligson D, Chang HR, Goodglick L (2006) Decreased expression of annexin A1 is correlated with breast cancer development and progression as determined by a tissue microarray analysis. Hum Pathol 37: 1583-1591
33. Srivastava M, Bubendorf L, Raffeld M, Bucher C, Torhorst J, Sauter G, Olsen C, Kallioniemi OP, Eidelman O, Pollard HB (2004) Prognostic impact of ANX7-GTPase in metastatic and HER2-negative breast cancer patients. Clin Cancer Res 10: 2344-2350
34. Srivastava M, Bubendorf L, Srikantan V, Fossom L, Nolan L, Glasman M, Leighton X, Fehrle W, Pittaluga S, Raffeld M, Koivisto P, Willi N, Gasser TC, Kononen J, Sauter G, Kallioniemi OP, Srivastava S, Pollard HB (2001) ANX7, a candidate tumor suppressor gene for prostate cancer. Proc Natl Acad Sci USA 98: 4575-4580
35. Syed SP, Martin AM, Haupt HM, Arenas-Elliot CP, Brooks JJ (2007) Angiostatin receptor annexin II in vascular tumors including angiosarcoma. Hum Pathol 38: 508-513
36. Tomas A, Futter C, Moss SE (2004) Annexin 11 is required for midbody formation and completion of the terminal phase of cytokinesis. J Cell Biol 165: 813-822
37. Vishwanatha JK, Salazar E, Gopalakrishnan VK (2004) Absence of annexin I expression in B-cell non-Hodgkin's lymphomas and cell lines. BMC Cancer 4: 8
38. Wang KL, Wu TT, Resetkova E, Wang H, Correa AM, Hofstetter WL, Swisher SG, Ajani JA, Rashid A, Hamilton SR, Albarracin CT (2006) Expression of annexin A1 in esophageal and esophagogastric junction adenocarcinomas: association with poor outcome. Clin Cancer Res 12: 4598-4604
39. Wozny W, Schroer K, Schwall GP, Poznanovic S, Stegmann W, Dietz K, Rogatsch H, Schaefer G, Huebl H, Klocker H, Schrattenholz A, Cahill MA (2007) Differential radioactive quantification of protein abundance ratios between benign and malignant prostate tissues: cancer association of annexin A3. Proteomics 7: 313-322
40. Xin W, Rhodes DR, Ingold C, Chinnaiyan AM, Rubin MA (2003) Dysregulation of the annexin family protein family is associated with prostate cancer progression. Am J Pathol 162: 255-261
41. Zimmermann U, Woenckhaus C, Pietschmann S, Junker H, Maile S, Schultz K, Protzel C, Giebel J (2004a) Expression of annexin II in conventional renal cell carcinoma is correlated with Fuhrman grade and clinical outcome. Virchows Arch 445: 368-374
42. Zimmermann U, Balabanov S, Giebel J, Teller S, Junker H, Schmoll D, Protzel C, Scharf C, Kleist B, Walther R (2004b) Increased expression and altered location of annexin IV in renal clear cell carcinoma: a possible role in tumour dissemination. Cancer Lett 209: 111-118
43. Zimmermann U, Woenckhaus C, Teller S, Venz S, Langheinrich M, Protzel C, Maile S, Junker H, Giebel J (2007) Expression of annexin AI in conventional renal cell carcinoma (CRCC) correlates with tumour stage, Fuhrman grade, amount of eosinophilic cells and clinical outcome. Histol Histopathol 22: 527-534
44. Zhang Y, Zhou ZH, Bugge TH, Wahl LM (2007) Urokinase-type plasminogen activator stimulation of monocyte matrix metalloproteinase-1 production is mediated by plasmin-dependent signaling through annexin A2 and inhibited by inactive plasmin. J Immunol 179: 3297-3304